Effect of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin on Forearm Endothelial Function in Diabetics
Not Applicable
Not yet recruiting
- Conditions
- diabetic patient
- Registration Number
- JPRN-jRCT1091220223
- Lead Sponsor
- Bonpei Takase
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Diabetic patients diabetic patients with HbA1c>7.0% (NGSP)
Exclusion Criteria
1. Contraindication of Teneligliptin
2. complicated with severe cardiac,renal and liver diseases
3. The patients whom the investigating physician disagree with enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method endothelial function
- Secondary Outcome Measures
Name Time Method Effect on plasma glucose levels